Osteoporosis

Good!

Romosuzumab is a humanized monoclonal antibody that binds to and inhibits sclerostin. 

By neutralizing sclerostin, romosuzumab exerts a dual effect on bone metabolism:

• Stimulates bone formation by activating the Wnt signaling pathway

• Inhibits bone resorption by downregulating osteoclast activity